Risk, regulation and the growing marginalisation of CAM

Review

Julie Stone. Complement Ther Clin Pract. 2010 Feb.

. 2010 Feb;16(1):1-2.

doi: 10.1016/j.ctcp.2009.11.003. Epub 2009 Dec 10.

No abstract available

Similar articles

Editorial: Regulation in complementary and alternative medicine: is it time for statutory regulation of CAM in the UK?
Smith GD. Smith GD. J Clin Nurs. 2010 Apr;19(7-8):901-3. doi: 10.1111/j.1365-2702.2010.03221.x. J Clin Nurs. 2010. PMID: 20492034 No abstract available.
Professional regulation in primary care: the long road to quality improvement.
Allsop J, Saks M. Allsop J, et al. Qual Prim Care. 2008;16(4):225-8. Qual Prim Care. 2008. PMID: 18718156 No abstract available.
Prince Charles delayed regulation of herbal medicines.
Kmietowicz Z. Kmietowicz Z. BMJ. 2015 May 14;350:h2642. doi: 10.1136/bmj.h2642. BMJ. 2015. PMID: 25977234 No abstract available.
Review: Statutory regulation of invasive complementary therapies, such as hijama and acupuncture, is the only effective way of ensuring both patient safety and good practice.
Mayberry JF. Mayberry JF. Med Leg J. 2018 Mar;86(1):23-31. doi: 10.1177/0025817217734482. Epub 2017 Oct 2. Med Leg J. 2018. PMID: 28967838 Review.
Complementary medicine: legal status of the non-licensed provider in the USA.
Cohen MH. Cohen MH. Complement Ther Nurs Midwifery. 2000 May;6(2):98-101. doi: 10.1054/ctnm.1999.0800. Complement Ther Nurs Midwifery. 2000. PMID: 10844750 Review.

Patients' expectations of private osteopathic care in the UK: a national survey of patients.
Leach CM, Mandy A, Hankins M, Bottomley LM, Cross V, Fawkes CA, Fiske A, Moore AP. Leach CM, et al. BMC Complement Altern Med. 2013 May 31;13:122. doi: 10.1186/1472-6882-13-122. BMC Complement Altern Med. 2013. PMID: 23721054 Free PMC article.